NCT05403047View on ClinicalTrials.gov

Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 31, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

October 31, 2025

Conditions

Hepatitis B Virus - Chronic Active

Interventions

DRUG

Fumarate, Tenofovir Disoproxil

all participants receive the intervention

All Listed Sponsors

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV